Wu You-Li, Wu Feng, Xu Cheng-Ping, Chen Guo-Lei, Zhang Yu, Chen Wei, Yan Xiao-Chu, Duan Guang-Jie
Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, China.
Diagn Pathol. 2019 Jan 15;14(1):5. doi: 10.1186/s13000-019-0779-3.
Mediastinal follicular dendritic cell sarcoma (FDCS) is extremely rare. Due to potential under-recognization of this disease, it happens to be misdiagnosed, especially on core needle biopsy. We report 3 cases of mediastinal FDCS and provide a literature review to improve better understanding of the tumor and to reduce misdiagnosis.
Three cases of mediastinal FDCS in our clinic practice were studied, including their core needle biopsy and resected specimens, and those cases reported previously in English literature were retrieved and analyzed.
The core needle biopsy of case 1 showed a tumor reminiscent of classical Hodgkin's lymphoma (CHL), while the resected mass was finally diagnosed with FDCS combined with hyaline-vascular Castleman's disease. Both the biopsy and resected tissue of case 2 were constitutive of the clear epithelioid cells with marked atypia. In both cases, definitive diagnoses were not made on core needle biopsy. In case 3, there were some areas morphologically similar to CHL, and some areas contained ovoid to spindle-shaped tumor cells with fascicular pattern. The analysis of 43 cases of mediastinal FDCS showed the age of patients were from 16 to 76 years old, the male to female ratio was 1.5:1, the maximal tumor diameters were 3-17 cm. 18 cases were underwent preoperative biopsy, whereas 15 (83.3%) of which were misdiagnosed initially, often as lymphoma. 32 patients had available follow-up data, the rates of recurrence, metastasis, and mortality were 12.5, 18.8 and 28.1%, respectively. Current limited data suggested no statistical differences between adverse prognosis and gender, age, tumor size, necrosis, or different therapeutics, respectively.
Mediastinal FDCS is a rare malignancy that has yet not been fully understood and been often misdiagnosed, particularly when making a diagnosis on core needle biopsy. Increased awareness of this enigmatic tumor is crucial to avoid diagnostic pitfalls.
纵隔滤泡树突状细胞肉瘤(FDCS)极为罕见。由于对该疾病可能认识不足,它容易被误诊,尤其是在粗针活检时。我们报告3例纵隔FDCS病例,并进行文献综述,以更好地了解该肿瘤并减少误诊。
研究了我们临床实践中的3例纵隔FDCS病例,包括其粗针活检和切除标本,并检索和分析了先前英文文献中报道的病例。
病例1的粗针活检显示肿瘤类似于经典霍奇金淋巴瘤(CHL),而切除的肿块最终诊断为FDCS合并透明血管型Castleman病。病例2的活检和切除组织均由具有明显异型性的透明上皮样细胞组成。在这两个病例中,粗针活检均未做出明确诊断。病例3中,有些区域在形态上类似于CHL,有些区域含有卵圆形至梭形肿瘤细胞,呈束状排列。对43例纵隔FDCS病例的分析显示,患者年龄为16至76岁,男女比例为1.5:1,肿瘤最大直径为3至17厘米。18例患者接受了术前活检,其中15例(83.3%)最初被误诊,常被误诊为淋巴瘤。32例患者有可用的随访数据,复发率、转移率和死亡率分别为12.5%、18.8%和28.1%。目前有限的数据表明,不良预后与性别、年龄、肿瘤大小、坏死或不同治疗方法之间无统计学差异。
纵隔FDCS是一种罕见的恶性肿瘤,尚未被充分了解,且常被误诊,尤其是在粗针活检诊断时。提高对这种神秘肿瘤的认识对于避免诊断陷阱至关重要。